Literature DB >> 3498584

Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function.

S E Schiff1, J Kurtzberg, R H Buckley.   

Abstract

Morphological, phenotypic and functional analyses were made of cells obtained at each step after successive treatments of 23 separate human bone marrow suspensions with soybean lectin and sheep erythrocytes (SRBC). The average total number of nucleated cells harvested was 1.9 X 10(10) and the final cell suspensions contained a mean of 1.9 X 10(9) nucleated cells or 9.2 +/- 4.8% of the initial counts. Monoclonal antibody analyses revealed that both T and B lymphocytes were present in every cell fraction in percentages similar to those found initially until after the first SRBC rosette-depletion. Moreover, both soy lectin agglutinated and non-agglutinated cells exhibited vigorous proliferative responses to phytohaemagglutinin and allogeneic cells. Following the SRBC depletions, no cells having T lymphocyte phenotypes or functions could be detected, whereas 5% of the cells reacted with a monoclonal antibody to B lymphocytes. The final fraction was composed predominantly of immature myeloid cells and blasts and was depleted of erythroid elements, lymphocytes and essentially all mature cells. It contained cells reactive with monoclonal antibodies recognizing undifferentiated T cell precursors (3A1), the transferrin receptor (5E9), and a human progenitor cell antigen (My-10). The final fraction was also enriched 10-100-fold for CFU-C and 5-10-fold for CFU-GEMN colonies. These studies fail to demonstrate selective removal of T lymphocytes from human bone marrow cells by soybean lectin agglutination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498584      PMCID: PMC1542765     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells.

Authors:  A W Burgess; E M Wilson; D Metcalf
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

2.  Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts.

Authors:  A A Fauser; H A Messner
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

3.  Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood.

Authors:  A A Fauser; H A Messner
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

4.  Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency.

Authors:  R I Schiff; R H Buckley; R B Gilbertsen; R S Metzgar
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

5.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

6.  Establishment of the DU.528 human lymphohemopoietic stem cell line.

Authors:  J Kurtzberg; S H Bigner; M S Hershfield
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

7.  Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.

Authors:  R H Buckley; S E Schiff; H A Sampson; R I Schiff; M L Markert; A P Knutsen; M S Hershfield; A T Huang; G H Mickey; F E Ward
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.

Authors:  A E Woolfrey; S Neudorf; A H Filipovich
Journal:  Thymus       Date:  1985

9.  Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow.

Authors:  B R Blazar; R R Quinones; K J Heinitz; E A Sevenich; A H Filipovich
Journal:  Exp Hematol       Date:  1985-02       Impact factor: 3.084

Review 10.  Phenotypic and functional characterization of human malignant T cells.

Authors:  E A Harden; B F Haynes
Journal:  Semin Hematol       Date:  1985-01       Impact factor: 3.851

View more
  6 in total

1.  Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism.

Authors:  M J Barrett; R H Buckley; S E Schiff; P C Kidd; F E Ward
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

Review 2.  Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.

Authors:  Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.

Authors:  E F Kent; J Crawford; H J Cohen; R H Buckley
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

Review 4.  Advances in the understanding and treatment of human severe combined immunodeficiency.

Authors:  R H Buckley
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

Review 5.  Use of lectins in immunohematology.

Authors:  Ajit C Gorakshakar; Kanjaksha Ghosh
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

6.  Long-term outcome of non-ablative booster BMT in patients with SCID.

Authors:  C L Teigland; R E Parrott; R H Buckley
Journal:  Bone Marrow Transplant       Date:  2013-02-11       Impact factor: 5.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.